Preparation method of nafamostat mesylate
During the synthesis of naphthalmust methanesulfonate, the esterification and cyanation reaction of 6-bromo-2-naphthol potassium and 4-guanidine-benzoyl chloride were solved, and the middle yield and purification of the prior art were solved. Complexity issues have achieved efficient preparation of naphthalmust methanesulfonate.
Patent Information
- Application Number
- CN202411032893.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-30
- Publication Date
- 2024-11-22
AI Technical Summary
During the existing synthesis of naphthalmust methanesulfonate, the difficulty of synthesis of 6-amidino-2-naphthol and the high tendency of oxidation of phenolic hydroxyl groups lead to problems with low yield and high purification complexity.
Esterification reaction was carried out using 6-bromo-2-naphthol potassium and 4-guanidine-benzoyl chloride, followed by cyanide reaction under the action of cyanide agent and catalyst, and finally obtained naphthalene molyb methanesulfonate through multiple steps simplifies the process flow and improves yield.
The yield of cyanide reaction is significantly improved, the process flow is simplified, the tedious steps of phenolic hydroxyl protection and deprotection are overcome, and the high yield preparation of naphthalmust methanesulfonate is achieved.
Smart Images

Figure CN118993950A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of organic synthesis, and in particular relates to a preparation method of nafamostat mesylate. Background Art
[0002] Nafamostat mesylate is a non-peptide protease inhibitor developed by Japan Tobacco. It was first launched in Japan in October 1986 in the form of freeze-dried powder injection. Clinical studies have shown that the drug is suitable for a variety of conditions, including acute pancreatitis, acute exacerbation of chronic pancreatitis, especially acute pancreatitis after pancreatography, pancreatitis caused by trauma, and acute pancreatitis complicated by surgery. In addition, it is also used to treat disseminated intravascular coagulation (DIC) and to prevent coagulation during extracorporeal circulation of blood.
[0003] The chemical structure of nafamostat mesylate is as follows: , In the current synthesis process, 6-amidino-2-naphthol is combined with 4-guanidinobenzoic acid through an esterification reaction, but the yield of this esterification step is low. One of the key difficulties is that 6-amidino-2-naphthol is difficult to synthesize, especially its phenolic hydroxyl group has a high tendency to oxidize in solvents, which not only directly reduces the overall yield, but also significantly increases the complexity of subsequent purification. Summary of the invention
[0004] In view of the shortcomings of the prior art, the object of the present invention is to provide a method for preparing nafamostat mesylate.
[0005] The purpose of the present invention is achieved through the following technical solutions: A method for preparing nafamostat mesylate comprises the following steps: (1) adding potassium 6-bromo-2-naphthol to a first organic solvent, cooling the solvent, adding 4-guanidino-benzoyl chloride to carry out an esterification reaction, adding water to precipitate after the reaction, and using ethyl acetate to obtain a first compound after pure crystallization; (2) adding the first compound, the cyaniding agent and the catalyst into the second organic solvent, heating the mixture under a protective atmosphere to carry out a cyanidation reaction, removing the excess cyaniding agent and the second organic solvent after the reaction, and extracting to obtain the second compound; (3) adding the second compound to a hydrochloric acid methanol solution to react, and after purification, adding the reaction product to an amine methanol solution to continue the reaction to obtain nafamostat; (4) Nafamostat is reacted with methanesulfonic acid to obtain nafamostat mesylate.
[0006] Preferably, the molar ratio of 6-bromo-2-naphthol potassium and 4-guanidino-benzoyl chloride in step (1) is 1-5:1-5.
[0007] Preferably, the cooling in step (1) is to -10 to -5°C, more preferably -5 to 0°C.
[0008] Preferably, the esterification reaction time in step (1) is 0.5 to 12 hours, and the esterification reaction is carried out in anhydrous and oxygen-free environment.
[0009] Preferably, the first organic solvent in step (1) is at least one of tetrahydrofuran, dioxane, DMSO, dichloromethane, pyridine, triethylamine, N,N-dimethylformamide, N,N-dimethylacetamide and N-methylpyrrolidone. More preferably, it is N,N-dimethylformamide or N,N-dimethylacetamide.
[0010] Preferably, in step (2), the molar ratio of the first compound, the cyaniding agent and the catalyst is 1-2:1-4:0.1-1.
[0011] Preferably, the temperature in step (2) is increased to 120-200°C, more preferably 150-170°C.
[0012] Preferably, the cyanation reaction time in step (2) is 3 to 24 hours, more preferably 4 to 6 hours.
[0013] Preferably, the specific steps of extracting the second compound in step (2) are: adding ethyl acetate and stirring to dissolve the sample, then filtering to separate solid impurities, and finally obtaining a pure product through crystallization.
[0014] Preferably, the second organic solvent in step (2) is at least one of N,N-dimethylformamide, N,N-dimethylacetamide and N-methylpyrrolidone, more preferably N,N-dimethylformamide or N,N-dimethylacetamide.
[0015] Preferably, the cyaniding agent in step (2) is at least one of cuprous cyanide, zinc cyanide, potassium ferrocyanide and zinc cyanide, more preferably potassium ferrocyanide or cuprous cyanide.
[0016] Preferably, the catalyst in step (2) is at least one of cuprous iodide, potassium iodide, tetrabutylammonium bromide, tetrabutylammonium iodide, hexadecyltrimethylammonium chloride, dodecyltrimethylammonium chloride, hexadecyltrimethylammonium bromide and dodecyltrimethylammonium bromide, more preferably at least one of cuprous iodide, hexadecyltrimethylammonium chloride and dodecyltrimethylammonium chloride.
[0017] Preferably, in step (3), the mass ratio of the second compound to the methanol solution of hydrochloric acid is 1-3:10-100.
[0018] Preferably, in step (3), the second compound is added to a hydrochloric acid methanol solution and reacted at a temperature below 0° C. for 24 hours to obtain a reaction product.
[0019] Preferably, the purification method in step (3) is: after filtration, washing with cold water.
[0020] Preferably, the mass ratio of the amine methanol solution in step (3) to the purified reaction product is 10-1000:1-10.
[0021] Preferably, the reaction time in step (3) is 2 to 24 hours.
[0022] Preferably, the concentration of the hydrochloric acid methanol solution in step (3) is 10% to 30%.
[0023] Preferably, the amine substance in the amine methanol solution in step (3) is at least one of ammonia gas, ammonia water and ammonium salt.
[0024] Preferably, the concentration of the amine methanol solution in step (3) is 15-20%.
[0025] Preferably, the specific steps of the reaction of nafamostat with methanesulfonic acid in step (4) are: dissolving nafamostat in alcohol, then adding methanesulfonic acid, stirring at room temperature for 10 to 24 hours, and removing the alcohol by reduced pressure distillation to prepare nafamostat mesylate.
[0026] Preferably, the alcohol is at least one of methanol, ethanol, propanol and butanol.
[0027] The reaction mechanism involved in the present invention is: Under anhydrous and oxygen-free conditions, 6-bromo-2-naphthol, a catalyst (such as cuprous iodide and a quaternary ammonium salt) and a cyaniding agent are dissolved in an organic solvent to carry out a catalytic cyanation reaction to obtain a product, 6-cyano-2-naphthyl-4'-guanidinobenzoate; then, the esterified product is dissolved in an alcohol solvent together with an acidic catalyst (i.e., hydrochloric acid) to carry out a Pinner reaction; next, an amine methanol solution is introduced into the system to carry out an aminolysis reaction to obtain nafamostat; finally, nafamostat and methanesulfonic acid are mixed in an alcohol solvent and stirred evenly to obtain nafamostat mesylate.
[0028] Compared with the prior art, the beneficial effects of the present invention include: The present invention adopts 6-bromo-2-naphthol potassium and 4-guanidinobenzoyl chloride as starting materials, effectively overcomes the difficulties in the esterification process, and significantly simplifies the synthesis route. In particular, in the key step of preparing nafamostat mesylate, the cyanation reaction is cleverly used, and iodide and quaternary ammonium salt are introduced as efficient catalysts. This strategy not only avoids the cumbersome steps of protecting and deprotecting the phenolic hydroxyl group, greatly simplifies the process flow, but also greatly improves the yield of the cyanation reaction, and finally achieves the high-yield preparation of nafamostat mesylate. BRIEF DESCRIPTION OF THE DRAWINGS
[0029] Figure 1 The figure is a reaction mechanism diagram of the preparation method of nafamostat mesylate of the present invention.
[0030] Figure 2 This is the hydrogen nuclear magnetic resonance spectrum of nafamostat mesylate prepared in an embodiment of the present invention.
[0031] Figure 3 The carbon nuclear magnetic resonance spectrum of nafamostat mesylate prepared in an embodiment of the present invention. DETAILED DESCRIPTION
[0032] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.
[0033] The 4-guanidino-benzoyl chloride described in the example was homemade, and the specific preparation method was as follows: 9 g of thionyl chloride was added to a single-necked flask containing 1.79 g of 4-guanidinobenzoic acid, the temperature was slowly raised to 80° C. and reacted at this temperature for 3 h. After the reaction was completed, the mixture was distilled under reduced pressure to prepare 4-guanidino-benzoyl chloride.
[0034] Potassium 6-bromo-2-naphthol was purchased from Hubei Jingli New Materials Co., Ltd.
[0035] Example 1 A preparation method of nafamostat mesylate, comprising the following steps: (1) 30 g (0.1 mol) of 6-bromo-2-naphthol potassium was dissolved in 200 mL of N,N-dimethylformamide (DMF), placed in a three-necked flask, and cooled to 0°C. At this time, a constant pressure dropping funnel with 20 g (0.1 mol) of 4-guanidino-benzoyl chloride was installed above the three-necked flask, and the acyl chloride was slowly added dropwise. After the addition was completed, the reaction mixture was stirred at room temperature for 12 h; then, 500 mL of water was added to the system, a large amount of solid precipitated, and pure crystallization was performed with ethyl acetate to obtain 36 g of the first compound with a yield of 92%.
[0036] (2) In a three-necked flask, add 8.9 g (0.1 mol) of cuprous cyanide, 19.8 g (0.05 mol) of the first compound and 1.9 g (0.01 mol) of cuprous iodide. In addition, add 0.018 g of hexadecyltrimethylammonium bromide and inject 100 mL of N,N-dimethylacetamide. Then, introduce nitrogen protection, heat the system to 145 °C and stir to react for 3 h. Subsequently, gradually add 100 mL of sodium hypochlorite solution to remove excess cyanide ions. Remove N,N-dimethylacetamide by vacuum distillation. After the system is cooled to room temperature, add 200 mL of ethyl acetate to dissolve the product. Filter by suction, concentrate the filtrate under reduced pressure, and cool and crystallize to obtain 16 g of the second compound.
[0037] (3) The second compound is added to 200 mL of a pre-prepared hydrochloric acid methanol solution (with a concentration of 15%), and the reaction is carried out at a temperature not exceeding 0° C. for 24 h. After purification, the product is transferred to 200 mL of an amine methanol solution (with a concentration of 20%, and the amine substance is ammonia gas) and the reaction is continued for 24 h to obtain nafamostat.
[0038] (4) Nafamostat was dissolved in 100 mL of methanol, followed by the addition of 10 mL of methanesulfonic acid. The mixture was stirred at room temperature for 24 h, and the methanol was removed by vacuum distillation to obtain a white solid, nafamostat mesylate, with a yield of 82%.
[0039] 1 H NMR (d 6 -DMSO) δ 2.5 (s,3H), 3.3 (s, 3H) 7.52-7.48 (d, 1H), 7.72-7.65(dd,1H), 8.1. -7.8(m,3H), 8.6 (s,1H), 9.35.4-9.15 (s,1H), 9.6-9.4(s,1H). 13 C NMR (d 6 -DMSO) 166.1, 164.5, 155.8, 150.9, 142.1, 136.1, 132.07,131.45, 130.27, 129.9, 125.9, 125.4, 124.9, 123.07,119.43, 25.95. Example 2 A preparation method of nafamostat mesylate, comprising the following steps: (1) 300 g (1 mol) of 6-bromo-2-naphthol potassium was dissolved in 2000 mL of N,N-dimethylformamide (DMF), placed in a three-necked flask, and cooled to 0°C. At this time, a constant pressure dropping funnel with 200 g (1 mol) of 4-guanidino-benzoyl chloride was installed above the three-necked flask, and the acyl chloride was slowly added dropwise. After 1 hour of dropping, the reaction mixture was stirred at room temperature for 12 hours; then, 30,000 mL of water was added to the system, and a large amount of solid precipitated. It was purified by crystallization from ethyl acetate to obtain 366 g of the first compound with a yield of 93.6%.
[0040] (2) In a three-necked flask, add 89g (1 mol) of cuprous cyanide, 198g (0.5 mol) of the first compound and 19g (0.1 mol) of cuprous iodide. In addition, add 0.18g of hexadecyltrimethylammonium bromide and inject 1000mL of N,N-dimethylacetamide. Then, introduce nitrogen protection, heat the system to 145°C and stir to react for 3h. Subsequently, gradually add 100mL of sodium hypochlorite solution to remove excess cyanide ions. Remove N,N-dimethylacetamide by vacuum distillation. After the system is cooled to room temperature, add 200mL of ethyl acetate to dissolve the product. Filter and concentrate the filtrate under reduced pressure. Cool and crystallize to obtain 169g of the second compound.
[0041] (3) The second compound is added to 2000 mL of a pre-prepared hydrochloric acid methanol solution (with a concentration of 15%), and the reaction is carried out at a temperature not exceeding 0° C. for 24 h. After purification, the product is transferred to 2000 mL of an amine methanol solution (with a concentration of 20%, and the amine substance is ammonia gas) and the reaction is continued for 24 h to obtain nafamostat.
[0042] (4) Nafamostat was dissolved in 1000 mL of methanol, followed by the addition of 30 mL of methanesulfonic acid. The mixture was stirred at room temperature for 24 h, and the methanol was removed by vacuum distillation to obtain a white solid, nafamostat mesylate, with a yield of 84%.
[0043] 1 H NMR (d 6 -DMSO) δ 2.5 (s,3H), 3.3 (s, 3H) 7.52-7.48 (d, 1H), 7.72-7.65(dd,1H), 8.1. -7.8(m,3H), 8.6 (s,1H), 9.35.4-9.15 (s,1H), 9.6-9.4(s,1H). 13 C NMR (d 6-DMSO) 166.1, 164.5, 155.8, 150.9, 142.1, 136.1, 132.07,131.45, 130.27, 129.9, 125.9, 125.4, 124.9, 123.07,119.43, 25.95. Example 3 A preparation method of nafamostat mesylate, comprising the following steps: (1) 300 g (1 mol) of 6-bromo-2-naphthol potassium was dissolved in 2000 mL of N-methylpyrrolidone (NMP), placed in a three-necked flask, and cooled to 0°C. At this time, a constant pressure dropping funnel with 200 g (1 mol) of 4-guanidino-benzoyl chloride was installed above the three-necked flask, and the acyl chloride was slowly added dropwise. After 1 hour of dropping, the reaction mixture was stirred at room temperature for 12 hours; then, 30,000 mL of water was added to the system, and a large amount of solid precipitated. It was purified by crystallization from ethyl acetate to obtain 352 g of the first compound with a yield of 90%.
[0044] (2) In a three-necked flask, add 89g (1 mol) of cuprous cyanide, 198g (0.5 mol) of the first compound and 19g (0.1 mol) of cuprous iodide. In addition, add 0.16g of dodecyltrimethylammonium bromide and inject 1000mL of N,N-dimethylacetamide. Then, introduce nitrogen protection, heat the system to 145°C and stir to react for 3h. Subsequently, gradually add 100mL of sodium hypochlorite solution to remove excess cyanide ions. Remove N,N-dimethylacetamide by vacuum distillation. After the system is cooled to room temperature, add 200mL of ethyl acetate to dissolve the product. Filter and concentrate the filtrate under reduced pressure. Cool and crystallize to obtain 169g of the second compound.
[0045] (3) The second compound is added to 2000 mL of a pre-prepared hydrochloric acid methanol solution (concentration of 20%), and the reaction is carried out at a temperature not exceeding 0° C. for 18 h. After purification, the product is transferred to 2000 mL of an amine methanol solution (concentration of 20%, the amine substance is ammonia gas) and the reaction is continued for 24 h to obtain nafamostat.
[0046] (4) Nafamostat was dissolved in 1000 mL of methanol, followed by the addition of 30 mL of methanesulfonic acid. The mixture was stirred at room temperature for 24 h, and the methanol was removed by vacuum distillation to obtain a white solid, nafamostat mesylate, with a yield of 76%.
[0047] 1 H NMR (d 6-DMSO) δ 2.5 (s,3H), 3.3 (s, 3H) 7.52-7.48 (d, 1H), 7.72-7.65(dd,1H), 8.1. -7.8(m,3H), 8.6 (s,1H), 9.35.4-9.15 (s,1H), 9.6-9.4(s,1H). 13 C NMR (d 6 -DMSO) 166.1, 164.5, 155.8, 150.9, 142.1, 136.1, 132.07,131.45, 130.27, 129.9, 125.9, 125.4, 124.9, 123.07,119.43, 25.95. The specific implementation of the present invention described above does not constitute a limitation on the protection scope of the present invention. Any other corresponding changes and modifications made based on the technical concept of the present invention should be included in the protection scope of the claims of the present invention.
Claims
1. A method for preparing nafamostat mesylate, characterized in that, The steps include: (1) adding 6-bromo-2-naphthol potassium to a first solvent, cooling and adding 4-guanidino-benzoyl chloride to carry out an esterification reaction, adding water to precipitate after the reaction, and obtaining a first compound after pure crystallization; (2) adding the first compound, the cyaniding agent and the catalyst into the second solvent, heating the solvent under a protective atmosphere to carry out a cyanidation reaction, and extracting the solvent to obtain the second compound after the reaction is completed; (3) adding the second compound to a hydrochloric acid methanol solution to react, and adding the purified product to an amine methanol solution to continue the reaction to obtain nafamostat; (4) Nafamostat is reacted with methanesulfonic acid to obtain nafamostat mesylate.
2. The method for preparing nafamostat mesylate according to claim 1, wherein In step (1), the molar ratio of 6-bromo-2-naphthol potassium and 4-guanidino-benzoyl chloride is 1-5:1-5; The cooling in step (1) is to a temperature of -10 to -5°C; The esterification reaction time of step (1) is 0.5 to 12 hours, and the esterification reaction is carried out in anhydrous and oxygen-free environment.
3. The method for preparing nafamostat mesylate according to claim 2, wherein The method of pure crystallization in step (1) is: pure crystallization using ethyl acetate; Step (1) the first solvent is at least one of tetrahydrofuran, dioxane, DMSO, dichloromethane, pyridine, triethylamine, N,N-dimethylformamide, N,N-dimethylacetamide and N-methylpyrrolidone; The cooling in step (1) is to a temperature between -5 and 0°C.
4. The method for preparing nafamostat mesylate according to claim 1, wherein Step (2) The molar ratio of the first compound, the cyaniding agent and the catalyst is 1-2:1-4:0.1-1; The heating in step (2) is to be raised to 120-200°C; The cyanation reaction time in step (2) is 3 to 24 hours.
5. The method for preparing nafamostat mesylate according to claim 4, wherein The heating in step (2) is to be raised to 150-170°C; The cyanation reaction time in step (2) is 4 to 6 hours.
6. The method for preparing nafamostat mesylate according to claim 1, wherein After the reaction in step (2), the excess cyaniding agent and the second solvent are removed, and then the second compound is obtained by extraction; The specific steps of extracting the second compound in step (2) are: adding ethyl acetate and stirring to dissolve the sample, then filtering to separate solid impurities, and finally obtaining a pure product through crystallization.
7. The method for preparing nafamostat mesylate according to claim 1, wherein Step (2) the second solvent is at least one of N,N-dimethylformamide, N,N-dimethylacetamide and N-methylpyrrolidone; The cyaniding agent in step (2) is at least one of cuprous cyanide, zinc cyanide, potassium ferrocyanide and zinc cyanide; The catalyst in step (2) is at least one of cuprous iodide, potassium iodide, tetrabutylammonium bromide, tetrabutylammonium iodide, hexadecyltrimethylammonium chloride, dodecyltrimethylammonium chloride, hexadecyltrimethylammonium bromide and dodecyltrimethylammonium bromide.
8. The method for preparing nafamostat mesylate according to claim 1, wherein Step (3) the mass ratio of the second compound to the methanol solution of hydrochloric acid is 1-3:10-100; The mass ratio of the amine methanol solution in step (3) to the purified reaction product is 10-1000:1-10.
9. The method for preparing nafamostat mesylate according to claim 1, wherein Step (3) adding the second compound to a hydrochloric acid methanol solution, and reacting at a temperature below 0° C. for 24 hours to obtain a reaction product; The purification method of step (3) is: after filtration, washing with cold water; The reaction time in step (3) is 2 to 24 hours; The amine substance in the amine methanol solution in step (3) is at least one of ammonia gas, ammonia water and ammonium salt.
10. The method for preparing nafamostat mesylate according to claim 1, characterized in that: The concentration of the hydrochloric acid methanol solution in step (3) is 10% to 30%; The concentration of the amine methanol solution in step (3) is 15-20%; The specific steps of the reaction of nafamostat with methanesulfonic acid in step (4) are as follows: dissolving nafamostat in alcohol, then adding methanesulfonic acid, stirring at room temperature for 10 to 24 hours, and removing the alcohol by vacuum distillation to prepare nafamostat mesylate.
Citation Information
Patent Citations
Method for preparing nafamostat hydrochloride and nafamostat mesylate
CN103012214A
Synthesis method of high-purity anti-hemagglutination medicine
CN117986161A
Inhibitors of factor Xa
US20020091116A1
